Much a t t e n t i o n i s being directed t o the incidence o f growth hormone deficiency and l i m i t s o f HCH-concentration i n res ons t o s t i m u l i are under debate. I n t h i s study 23 serum samples from foul patients were obtained during various stimulation t e s t and analxzed by means of the following k i t s : Pharmacia (RIA l o o ) , CIS (dB-HGH-RIA e u a l t o Sorin HGHK-2), Serono (HCH? RIA) and Hybritech andem em-8-HGH). A l l r e s u l t s were obtained I n mU/l, the f l r s i three k i t s being standardized against W H O 66/217 and the l a s t against HS 2243 E NIH. Pharmacia RIA-100 was the " i n house method" ( x ) and the f o l l o w i n correlations between the r e s u l t s samp!es o f biosynth&ic HGH:'~-HGH was'diluted t o 22.1 mU/1 and P i t u l l a r y standard P-tICIi d i l u t e d t o 18.8 mU/l, both from Nordisk Gentofte oave followino r e s u l t s lmU/l): Serono 24;O I llvbritech 18.0 I n cbnclusion methods bas6d on one antibody-RIA i~i~=~o r i n , Serono) gave the highest l e v e l s of HGH i n plasma samples. O f the two IRMA-kits, H b r l t e c h w i t h two monoclonal antibodies gave the lowest resulrs. Accordingly the d i v i d i n g l i n e between normal and p a r t i n l deficiency i s closely l i n k e d t o the HGH assay chosen.
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J. Girard (introd. by J. Girard). University Children's Hospital, Basel, Switzerland, and 1 ) Service de PBdiatrie e t Laboratoire d1Endocri-nologie, U 168, CHU Rangueil, Toulouse, France. DOES URINARY GROWTH HORMONE (GH) REFLECT PLASMA GROWTI HORMONE LEVELS? I n 40 children, a 24 h-plasma GH p r o f i l e has been compared t o u r i . nary GH excretion. Plasma was assayed w i t h a conventional radioim. munoassay ( k i t CEA). For urine, a radiometric assay has been develo ed with a solid-phase goat antibody f o r immunextraction and a 11!5 monoclonal antibody for quantification. The assay i s insen. s i t i v e t o pH 5-8, NaCl/urea 0.1-0.5 mol and t o sample volumes up t o 10 m l . The s e n s i t i v i t y o f 2 pg i n the standard r e s u l t s i n a de. t e c t i o n l i m i t o f 1 pg/ml, i f 2.5 m l o f urine are used. Coefficients of v a r i a t i o n are 10-14% f o r inter-. and 2.5-3.5% f o r i n t r a . assay. Plasma GH was expressed as integrated concentration (IC, ng/ml/h) per 24 h or night/day periods, urinary GH as pg per 24 h or nightlday and was related t o creatinine. A radiometric assay f o r GH was applied t o unprocessed urine (technical d e t a i l s previously described). A s i g n i f i c a n t correlat i o n between plasma p r o f i l e s and urinary GH excretion has been found (i.e. 24 h plasma integrated concentrations (1C) t o urine pg/24 h, r = 0.45. Plasma 1C 24 h t o n i g h t urine GH/creatinine 0.69, n i g h t plasma 1C t o n i g h t urine 0.58. for a l l correlations N = 40). I n 155 24 h-urines o f "normal" children ( p a r t l y referred f o r suspected growth problems), a mean GH-excretion o f 6.2 2 6.5 ng/24 h (median 4.1, P. 10 1.3, P. 90 13.6) has been found. No clear r e l a t i o n was found t o chronological age, bone age or pubert y ratings. 10 patients with "precocious puberty" (5 idiopathic, 5 treated CAH) had a mean excretion o f 9.7 2 5.4 (median 8.4, P. 10 4.6, P. 90 19). I n active acromegaly, the values varied from 73 t o 500 ng/24 h. Patients w i t h "complete" (N = 9) and " p a r t i a l " (N = 7) GH-deficiency had a mean (median) excretion o f 0.79 (0.75) and 3.3 (1.8) ngl24 h o f f therapy. The values i ncreased t o 6.2 (3.8) and 11.3 (10.5) ng/24 h during therapy ( 2 11 d a i l y s.c.). Before more conclusions can be drawn, the important i n t r a i n d i v i d u a l v a r i a t i o n o f GH-excretion has t o be considered. Nevertheless, urinary GH mirrors an actual GH-production over a set time and can be applied t o c l i n i c a l states with suspected "at normal" GH-production or f o r therapy survey.
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WEASUREUENT OF URINARY GROWTH HORUONE (UGH) BY A SENSITIVE EYZYUE IWnUNOUETRIC ASSAY (EIA) I N CHILDREY
An EIA developed f o r the measurement of serum GH. was adapted f o r the measurement of UGH. Due t o the very low l e v e l s o f GH, urine samples are r o u t i n e l y dialyzed and concentrated a t least 15 f o l d by c e n t r i f u g a l u l t r a f i l t r a t i o n . Urine samples collected i n p l a s t i c tubes containing BSA ( l g l l ) are stored a t -20°C u n t i l analyzed f o r GH and creatinine (CR). Under these conditions GH i s stable f o r a t least 2 months. Wean recovery of GH a f t e r d i a l y s i s and concentration i s 91.4%. The s e n s i t i v i t y of the assay i s 0.4 pgltube. The intraassay and interassay c o e f f i c i e n t s of v a r i a t i o n are respectively 4.9% and 5.5% a t a concentration of 4.5 pglml.
The c e n t r i f u g a l u l t r a f i l t r a t i o n step requires approximately 45' per batch. Using t h i s method we analyzed first-morning urine samples of healthy children and of c h i l d r e n r e f e r r e d f o r short stature. The r e s u l t s i n the healthy c h i l d r e n vary from 5 t o 100 ng GHlg CR. I n children w i t h docuwented GH deficiency r e s u l t s are ( 3 ng GHlg CR. I n children w i t h intermediate GH response t o ITT and/or ARG r e s u l t s range from 3 t o 6 ng GHlg CR. Furthermore, we found a highly s i g n i f i c a n t c o r r e l a t i o n between UGH and peak serum GH during ITT or ARC provocation tests. From our r e s u l t s we conclude t h a t the measurement of UGH i n morning urine r e f l e c t s night-GH production. The effectiveness of t h i s parameter f o r diagnostic purpose has t o be further studied, due t o the large day t o day v a r i a t i o n of measured UGH i n i n d i v i d u a l children. Glostrup; '~o;disk Centofte.
A SENSITIVE ELISA FOR THE MEASUREMENT OF C t i I N SERUM, BLOOD AND URINE
A sensitive sandwich ELISA for CH was developed using guinea-pig (CP) polyclonal l y C to coat microtitre plates (which can be stored for u p to 3 months).
The standard was 22K biosynthetic hCH (2.97Ulmg).
Assay volume was 100p1 which could include u p to 2 0~1 o f serum, plasma or blood i n buffer, (0.04molll sodium phosphate, pH7.4, containing human serum albumin 6g11). or 1 0 0~1 o f dialysed urine.
Total assay time was 16hrs.
The conjugate was a peroxidase labelled Fabl-fragment o f GP anti-hCH with 0-phenylenediamine as the substrate f o r the enzymatic reaction.
Optical density was read a t 490nm.
The detection limit was 0.5 nanounitslwell. The working assay range using 2 0~1 o f serum was 0.05-15mUll. The inter assay coefficients o f variation were 6.8% a t 0.15mU/I, 2.4% a t 2.2mUll and 6.9% a t 11.6mUll (ESPE 1987) . There was no evidence o f desensitization of the hypothalamo-pituitary axis over a range of doses from 7.5-120nglkglmin.
We now report a study o f treatment of 8 children with continuous CHRH infusion for six months.
All were short, slowly growing prepubertal children w i t h peak GH responses to insulin-induced hypoglycaemia o f 10-20mull.
24 hour CH profiles were performed before treatment, o n Day 1, a t 5 weeks, three months and six months into treatment. CHRH (1-29) was infused continuously subcutaneously a t a rate o f 60nglkglmin.
Sum of CH pulse amplitudes over 24 hours rose from a baseline value o f 96.6mu11124hrs on Day 1. This rise was highly statistically significant and d i d n o t change f u r t h e r with time.
The increment of g r o w t h hormone secretion was accompanied b y a significant increase in growth velocity from 4.4cmlyear (range 3.6-5.1) to 7.6cmlyear (range 4.8-11.7) (p=0.02).
